drugset / Trial / NCT02439541
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy
Phase 1/2
Unknown
40 enrolled
Affiliated Hospital to Academy of Military Medical Sciences
Ivy Institute of Stem Cells Co. Ltd · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Phase I-II Clinical Trial-Safety and efficacy of umbilical cord derived mesenchymal stem cells (UC-MSCs) in patients with chronic heart ischemia cohort and perspective study.
Timeline
- Start
- 2015-05
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1e+07 cells | Other |